Form 8-K · Current report
Medtronic 8-K, filed Sep 1, 2026
- Filed
- CIK
- 0001613103
- Accession no.
- 0001628280-26-059697
Summary
The Medtronic plc (NYSE: MDT) reported first quarter fiscal 2027 revenue of $9.756 billion, up 13.7% as reported and on an organic basis, with GAAP diluted EPS of $1.14 and non-GAAP diluted EPS of $1.45, and raised its full-year fiscal 2027 organic revenue growth guidance to 7.25%–7.75% and non-GAAP diluted EPS guidance to $5.94–$6.00. Chairman and CEO Geoff Martha attributed the quarter's strength to breadth across businesses and newer growth platforms, while CFO Thierry Piéton said the results enabled the guidance increase.
Key points
- Cardiovascular portfolio revenue rose 19.5% as reported and 18.9% organic, led by 88% growth in Cardiac Ablation Solutions and 15% growth in Cardiac Rhythm Management.
- Neuroscience revenue rose 9.3% organic, with 15% growth in Pelvic Health as Altaviva contributed meaningfully, and Medical Surgical revenue rose 10.2% organic.
- Medtronic announced an expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmias, FDA clearance for the Touch Surgery Aide next-generation computing platform, a strategic investment in Pi-Cardia, and a partnership with Cornerstone Robotics.
- Medtronic completed the acquisitions of Scientia Vascular and SPR Therapeutics, and said an extra fiscal week benefited Q1 organic growth by roughly $570 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition On September 1, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2027 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report. Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated September 1, 2026 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). Exhibit 99.1: EX-99.1 2 exhibit991-fy27q1earningsr.htm EX-99.1 Exhibit 99.1 NEWS RELEASE FOR IMMEDIATE RELEASE Medtronic reports first quarter fiscal 2027 results; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.